ADA: Once-Weekly Survodutide Linked to Drop in Body Weight in Obesity

WEDNESDAY, June 10, 2026-- For adults with obesity without diabetes, once-weekly survodutide, an investigational glucagon receptor-glucagon-like peptide-1 receptor dual agonist, is associated with greater reductions in body weight than placebo...